Anaphylaxis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Medication Type (Epinephrine, Antihistamines, Steroids, Beta-Agonist, and Others), Route of Administration (Oral, Parenteral, and Others), Allergy Type (Food Allergy, Medications, Insect Stings, and Others), and Distribution Channel (Hospital Pharmacies, Retail Sales, and Others)

Publication Month: Jun 2021 | Report Code: TIPRE00022791 | No. of Pages: 203 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The anaphylaxis treatment market is expected to reach US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% during 2021–2028.

 

Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response. As per the Asthma and Allergy Foundation of America (AAFA), in the US, every year, there are around 200,000 hospital visits due to food allergies. The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. However, poor accessibility to epinephrine auto-injectors in low-income countries hinders the market growth.  

 

Lucrative Regions for Anaphylaxis Treatment Market

Lucrative Regions for Anaphylaxis Treatment Market

Get more information on this report :



Market Insights


Rising Incidence of Anaphylaxis

Anaphylaxis is a severe, lifethreatening allergic reaction caused by vulnerability to allergens (foods, insect stings, or medicines) identified as a non-self by a human body. Typical indications of this condition include swallowing and breathing difficulties, skin redness and itching, accelerated heart rate, wheezing, rapid breathing rate, and lowering blood pressure. The incidence of anaphylaxis is increasing around the world. According to the National Institute for Health and Care Excellence (NICE), anaphylaxis causes more than 20 deaths every year in the UK. As per the European Academy of Allergy and Clinical Immunology data, ~150 million Europeans suffer from chronic allergic diseases every year. Therefore, the rising incidence of allergies is leading to surge in anaphylaxis cases. Moreover, as per the Allergy Facts by the American College of Allergy, Asthma & Immunology, more than 50 million people experience different types of allergies every year.

 

1–15% of the US population is at the risk of having an anaphylactic reaction when exposed to one or more allergens, and up to 1% of these patients die due to anaphylaxis. The condition results in ~1,500 deaths per year in the US; also list allergies as the sixth-leading circumstance of chronic illness. Moreover, as per the Asthma and Allergy Foundation of America (AAFA), due to increasing food allergic reactions, the number of hospital visits has increased. Food allergies are the cause of more than 200,000 emergency room (ER) visits annually. Food Allergy Research & Education states that more than 32 million Americans live with life-threatening food allergies. Due to the growing prevalence of allergies, the economic burden on healthcare systems in many countries is increasing. For instance, according to Allergy Facts, the annual cost of managing the cases of allergies is more than US$ 18 billion in the US. Thus, the burgeoning incidence of anaphylaxis is driving the growth of the market.

 

Medication Type -Based Insights

Based on medication type, the anaphylaxis treatment market is segmented into epinephrine, antihistamines, steroids, beta-agonist, and others. The epinephrine segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

 

Anaphylaxis Treatment Market, by Medication Type– 2020 and 2028

Anaphylaxis Treatment Market, by Medication Type– 2020 and 2028

Get more information on this report :


 

Route of Administration -Based Insights

Based on route of administration, the anaphylaxis treatment market is segmented into oral, parenteral, and others. The parenteral segment held the largest share of the market in 2020, whereas the oral segment is anticipated to register the highest CAGR of 8.9% in the market during the forecast period.

 

Allergy Type-based Insights

Based on allergy type, the anaphylaxis treatment market is segmented into food allergy, medications, insect stings, and others. The food allergy segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.

 

Distribution Channel-based Insights

Based on distribution channel, the anaphylaxis treatment market is segmented into hospital pharmacies, retail sales, drug store mail, and others. The retail sales segment held the largest share of the market in 2020 and is estimated to register the highest CAGR in the market during the forecast period.

 

Strategic Insights

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the anaphylaxis treatment market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

 

Anaphylaxis Treatment Market – by Medication Type

  • Epinephrine
  • Antihistamines
  • Steroids
  • Beta-Agonist
  • Others

Anaphylaxis Treatment Market – by Route of Administration

  • Oral
  • Parenteral
  • Others

Anaphylaxis Treatment Market – by Allergy Type

  • Food Allergy
  • Medications
  • Insect Stings
  • Others

Anaphylaxis Treatment Market – by Distribution Channel

  • Hospital Pharmacies
  • Retail Sales
  • Others

Anaphylaxis Treatment Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

 

Company Profiles

  • Amneal Pharmaceuticals Inc.
  • Bioprojet
  • Mylan N.V.
  • Adamis Pharmaceutical Corporation
  • Abbott
  • Pfizer Inc.
  • Glaxosmithkline Plc.
  • Merck And Co., Inc.
  • Teva Pharmaceutical Industries Ltd.  
  • ALK-ABELLó   

 

1.            Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Anaphylaxis Treatment Market – By Medication Type

1.3.2        Global Anaphylaxis Treatment Market – By Application

1.3.3        Global Anaphylaxis Treatment Market – By Allergy Type

1.3.4        Global Anaphylaxis Treatment Market – By End User

1.3.5        Global Anaphylaxis Treatment Market – By Geography

2.            Anaphylaxis Treatment Market – Key Takeaways

3.            Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.            Global Anaphylaxis Treatment Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific – PEST Analysis

4.2.4        Middle East and Africa (MEA) – PEST Analysis

4.2.5        South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.            Anaphylaxis Treatment Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Rising Incidence of Anaphylaxis

5.1.2        Recent Approvals for Epinephrine

5.2       Market Restraints

5.2.1        Poor Access to Epinephrine Auto-Injectors in Low-Income Countries

5.3       Market Opportunities

5.3.1        Rise in Cases of Allergies Post Administration of COVID-19 Vaccines

5.4       Future Trends

5.4.1        Novel Drug Delivery Systems

5.5       Impact Analysis

6.            Anaphylaxis Treatment Market – Global Analysis

6.1       Global Anaphylaxis Treatment Market Revenue Forecast and Analysis

6.2       Global Anaphylaxis Treatment Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.            Anaphylaxis Treatment Market Analysis – By Medication Type

7.1       Overview

7.2       Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)

7.3       Epinephrine

7.3.1        Overview

7.3.2        Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4       Antihistamines

7.4.1        Overview

7.4.2        Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5       Steroids

7.5.1        Overview

7.5.2        Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.6       Beta-Agonist

7.6.1        Overview

7.6.2        Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.7       Others

7.7.1        Overview

7.7.2        Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.            Anaphylaxis Treatment Market Analysis – By Route of Administration

8.1       Overview

8.2       Anaphylaxis Treatment Market Revenue Share, by Route of Administration (2020 and 2028)

8.3       Oral

8.3.1        Overview

8.3.2        Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.4       Parenteral

8.4.1        Overview

8.4.2        Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.5       Others

8.5.1        Overview

8.5.2        Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.            Anaphylaxis Treatment Market Analysis – By Allergy Type

9.1       Overview

9.2       Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028, (%)

9.3       Food Allergy

9.3.1        Overview

9.3.2        Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.4       Medications

9.4.1        Overview

9.4.2        Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.5       Insect Stings

9.5.1        Overview

9.5.2        Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.6       Others

9.6.1        Overview

9.6.2        Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.         Anaphylaxis Treatment Market Analysis and Forecast –  By Distribution Channel

10.1    Overview

10.2    Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)

10.3    Retail Sales

10.3.1     Overview

10.3.2     Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

10.4    Hospital Pharmacies

10.4.1     Overview

10.4.2     Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

10.5    Others

10.5.1     Overview

10.5.2     Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

11.         Global Anaphylaxis Treatment Market – Geographical Analysis

11.1    North America: Anaphylaxis Treatment Market

11.1.1     Overview

11.1.2     North America: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.3     North America: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.4     North America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.5     North America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.6     North America: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.7     North America: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.8     North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

11.1.8.1   US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1.1    US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1.2    US: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.8.1.3    US: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.8.1.4    US: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.1.8.1.5    US: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.8.1.6    US: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.8.2   Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2.1    Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2.2    Canada: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.8.2.3    Canada: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.2.4    Canada: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.2.5    Canada: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.8.2.6    Canada: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.8.3   Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.3.1    Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.3.2    Mexico: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.1.8.3.3    Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.3.4    Mexico: Anaphylaxis Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.3.5    Mexico: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.1.8.3.6    Mexico: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.2    Europe: Anaphylaxis Treatment Market

11.2.1     Overview

11.2.2     Europe: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)

11.2.3     Europe: Anaphylaxis Treatment Market, by Device, 2019–2028 (USD Million)

11.2.4     Europe: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.5     Europe: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.6     Europe: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)

11.2.7     Europe: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.2.8     Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

11.2.8.1   Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.1.1    Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.1.2    Germany: Anaphylaxis Treatment Market, by Medication Type 2019–2028 (USD Million)

11.2.8.1.3    Germany: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.8.1.4    Germany: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.8.1.5    Germany: anaphylaxis treatment Market, by Allergy Type 2019–2028 (USD Million)

11.2.8.1.6    Germany: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.2.8.2   UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.2.1    UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.2.2    UK: Anaphylaxis Treatment Market, Medication Type, 2019–2028 (USD Million)

11.2.8.2.3    UK: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.8.2.4    UK: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.8.2.5    UK: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)

11.2.8.2.6    UK: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.2.8.3   France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.3.1    France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.3.2    France: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.2.8.3.3    France: Epinephrine Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.8.3.4    France: Others Treatment Market, by Route of Administration 2019–2028 (USD Million)

11.2.8.3.5    France: Anaphylaxis Treatment Market, by Allergy Type 2019–2028 (USD Million)

11.2.8.3.6    France: Anaphylaxis Treatment Market, by Distribution Channel 2019–2028 (USD Million)

11.2.8.4   Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.4.1    Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.4.2    Italy: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.2.8.4.3    Italy: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.4.4    Italy: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.4.5    Italy: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.2.8.4.6    Italy: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.8.5   Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.5.1    Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.5.2    Spain: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.2.8.5.3    Spain: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.5.4    Spain: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.5.5    Spain: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.2.8.5.6    Spain: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.8.6   Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.6.1    Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.6.2    Rest of Europe: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.2.8.6.3    Rest of Europe: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.6.4    Rest of Europe: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.6.5    Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.2.8.6.6    Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3    Asia Pacific: Anaphylaxis Treatment Market

11.3.1     Overview

11.3.2     Asia Pacific: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)

11.3.3     Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.4     Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.5     Asia Pacific: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.6     Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.7     Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3.8     Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

11.3.8.1   Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.1.1    Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.1.2    Japan: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.8.1.3    Japan: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.1.4    Japan: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.1.5    Japan: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.8.1.6    Japan: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3.8.2   China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.2.1    China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.2.2    China: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.8.2.3    China: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.2.4    China: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.2.5    China: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.8.2.6    China: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3.8.3   India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.3.1    India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.3.2    India: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.8.3.3    India: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.3.4    India: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.3.5    India: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.8.3.6    India: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3.8.4   South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.4.1    South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.4.2    South Korea: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.8.4.3    South Korea: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.4.4    South Korea: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.4.5    South Korea: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.8.4.6    South Korea: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3.8.5   Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.5.1    Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.5.2    Australia: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.8.5.3    Australia: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.5.4    Australia: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.5.5    Australia: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.8.5.6    Australia: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.3.8.6   Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.6.1    Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.6.2    Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.3.8.6.3    Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.6.4    Rest of Asia Pacific: Others Treatment Market, by Route of Administration, 2019–2028 (USD Million)

11.3.8.6.5    Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.3.8.6.6    Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.4    Middle East & Africa: Anaphylaxis Treatment Market

11.4.1     Overview

11.4.2     Middle East & Africa: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)

11.4.3     Middle East & Africa: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.4.4     Middle East & Africa: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.5     Middle East & Africa: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.6     Middle East & Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.4.7     Middle East & Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.4.8     Middle East and Africa: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

11.4.8.1   Saudi Arabia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.1.1    Saudi Arabia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.1.2    Saudi Arabia: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.4.8.1.3    Saudi Arabia: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.1.4    Saudi Arabia: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.1.5    Saudi Arabia: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.4.8.1.6    Saudi Arabia: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.4.8.2   UAE: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.2.1    UAE: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.2.2    UAE: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.4.8.2.3    UAE: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.2.4    UAE: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.2.5    UAE: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.4.8.2.6    UAE: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.4.8.3   South Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.3.1    South Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.3.2    South Africa: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.4.8.3.3    South Africa: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.3.4    South Africa: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.3.5    South Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.4.8.3.6    South Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.4.8.4   Rest of Middle East and Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.4.1    Rest of Middle East and Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.4.8.4.2    Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Medication Type, 2019–2028 (USD Million)

11.4.8.4.3    Rest of Middle East and Africa: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.4.4    Rest of Middle East and Africa: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.4.8.4.5    Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Allergy Type, 2019–2028 (USD Million)

11.4.8.4.6    Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Distribution Channel, 2019–2028 (USD Million)

11.5    South and Central America: Anaphylaxis Treatment Market

11.5.1     Overview

11.5.2     South and Central America: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (USD Million)

11.5.3     South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.5.4     South and Central America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.5     South and Central America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.6     South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)

11.5.7     South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)

11.5.8     South and Central America: Anaphylaxis Treatment Market Share by Country – 2020 & 2028, (%)

11.5.8.1   Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.5.8.1.1    Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.5.8.1.2    Brazil: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.5.8.1.3    Brazil: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.8.1.4    Brazil: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.8.1.5    Brazil: Anaphylaxis Treatment Market, by Allergy Type, 2019-2028 (USD Million)

11.5.8.1.6    Brazil: Anaphylaxis Treatment Market, by Distribution Channel, 2019-2028 (USD Million)

11.5.8.2   Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.5.8.2.1    Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.5.8.2.2    Argentina: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.5.8.2.3    Argentina: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.8.2.4    Argentina: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.8.2.5    Argentina: Anaphylaxis Treatment Market, by Allergy Type, 2019 -2028 (USD Million)

11.5.8.2.6    Argentina: Anaphylaxis Treatment Market, by Distribution Channel, 2019 -2028 (USD Million)

11.5.8.3   Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.5.8.3.1    Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts to 2028 (USD Million)

11.5.8.3.2    Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type, 2019 -2028 (USD Million)

11.5.8.3.3    Rest of South and Central America: Epinephrine Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.8.3.4    Rest of South and Central America: Others Treatment Market by Route of Administration, 2019–2028 (USD Million)

11.5.8.3.5    Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type, 2018-2027 (USD Million)

11.5.8.3.6    Rest of South and Central America: Anaphylaxis Treatment Market, by Distribution Channel, 2018-2027 (USD Million)

12.         Impact Of COVID-19 Pandemic on Global Anaphylaxis Treatment Market

12.1    North America: Impact Assessment of COVID-19 Pandemic

12.2    Europe: Impact Assessment of COVID-19 Pandemic

12.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

12.4    Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.5    South and Central America: Impact Assessment of COVID-19 Pandemic

13.         Anaphylaxis Treatment Market–Industry Landscape

13.1    Overview

13.2    Growth Strategies Done by the Companies in the Market, (%)

13.3    Organic Developments

13.3.1     Overview

13.4    Inorganic Developments

13.4.1     Overview

14.         Company Profiles

14.1    Abbott

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2    Adamis Pharmaceuticals Corporation

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3    ALK-Abelló A/S

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4    Amneal Pharmaceuticals, Inc.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5    BIOPROJET

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6    GlaxoSmithKline plc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7    Merck & Co., Inc.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8    MYLAN N.V.

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9    Pfizer Inc.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10 TEVA PHARMACEUTICAL INDUSTRIES LTD

14.10.1   Key Facts

14.10.2   Business Description

14.10.3   Products and Services

14.10.4   Financial Overview

14.10.5   SWOT Analysis

14.10.6   Key Developments

15.         Appendix

15.1    About the Insight Partners

15.2    Glossary of Terms, Anaphylaxis Treatment Market

 

LIST OF TABLES

Table 1.            North America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 2.            North America Epinephrine Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 3.            North America: Others Treatment Market Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.            North America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 5.            North America Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 6.            US: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 7.            US: Epinephrine Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 8.            US: Others Treatment Market by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 9.            US: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          US Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Canada: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13.          Canada: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Canada: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Canada Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 16.          Mexico: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 17.          Mexico: Anaphylaxis Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 18.          Mexico: Anaphylaxis Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 19.          Mexico: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          Mexico Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21.          Europe: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 22.          Europe: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 23.          Europe: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.          Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 25.          Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 26.          Germany: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 27.          Germany: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 28.          Germany: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 29.          Germany: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 30.          Germany: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 31.          UK: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 32.          UK: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 33.          UK: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 34.          UK: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 35.          UK: Anaphylaxis Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Million)

Table 36.          France: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 37.          France: Epinephrine Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 38.          France: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 39.          France: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 40.          France Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 41.          Italy: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 42.          Italy: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 43.          Italy: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 44.          Italy: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 45.          Italy: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 46.          Spain: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 47.          Spain: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 48.          Spain: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 49.          Spain: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 50.          Spain: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 51.          Rest of Europe: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 52.          Rest of Europe: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 53.          Rest of Europe: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 54.          Rest of Europe: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 55.          Rest of Europe: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 56.          Asia Pacific: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 57.          Asia Pacific: Anaphylaxis Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 58.          Asia Pacific: Others Treatment Market Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 59.          Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 60.          Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 61.          Japan: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 62.          Japan: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 63.          Japan: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 64.          Japan: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 65.          Japan: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 66.          China: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 67.          China: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 68.          China: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 69.          China: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 70.          China: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 71.          India: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 72.          India: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 73.          India: Others Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 74.          India: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 75.          India: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 76.          South Korea: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 77.          South Korea: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 78.          South Korea: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 79.          South Korea: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 80.          South Korea: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 81.          Australia: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 82.          Australia: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 83.          Australia: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 84.          Australia: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 85.          Australia: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 86.          Rest of Asia Pacific: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 87.          Rest of Asia Pacific: Epinephrine Treatment Market, by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 88.          Rest of Asia Pacific: Others Treatment Market, by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 89.          Rest of Asia Pacific: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 90.          Rest of Asia Pacific: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 91.          Middle East & Africa: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 92.          Middle East & Africa: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 93.          Middle East & Africa: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 94.          Middle East & Africa: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028  (USD Million)

Table 95.          Middle East & Africa: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028  (USD Million)

Table 96.          Saudi Arabia: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 97.          Saudi Arabia: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 98.          Saudi Arabia: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 99.          Saudi Arabia: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 100.       Saudi Arabia: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 101.       UAE: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 102.       UAE: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 103.       UAE: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 104.       UAE: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 105.       UAE: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 106.       South Africa: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 107.       South Africa: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 108.       South Africa: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 109.       South Africa: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 110.       South Africa: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 111.       Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Medication Type– Revenue and Forecast to 2028 (USD Million)

Table 112.       Rest of Middle East and Africa: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 113.       Rest of Middle East and Africa: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 114.       Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 115.       Rest of Middle East and Africa: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 116.       South and Central America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 117.       South and Central America: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 118.       South and Central America: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 119.       South and Central America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 120.       South and Central America: Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 121.       Brazil: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 122.       Brazil: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 123.       Brazil: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 124.       Brazil: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 125.       Brazil Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 126.       Argentina: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 127.       Argentina: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 128.       Argentina: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028  (USD Million)

Table 129.       Argentina: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 130.       Argentina Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 131.       Rest of South and Central America: Anaphylaxis Treatment Market, by Medication Type – Revenue and Forecast to 2028 (USD Million)

Table 132.       Rest of South and Central America: Epinephrine Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 133.       Rest of South and Central America: Others Treatment Market by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 134.       Rest of South and Central America: Anaphylaxis Treatment Market, by Allergy Type – Revenue and Forecast to 2028 (USD Million)

Table 135.       Rest of South and Central America Anaphylaxis Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 136.       Organic Developments Done by Companies

Table 137.       Inorganic Developments Done by Companies

Table 138.       List of Abbreviation

 

LIST OF FIGURES

Figure 1.           Anaphylaxis Treatment Market Segmentation

Figure 2.           Anaphylaxis Treatment Market Segmentation, By Region

Figure 3.           Anaphylaxis Treatment Market Overview

Figure 4.           Epinephrine Segment Held Largest Share of Anaphylaxis Treatment Market

Figure 5.           Asia Pacific to Show Significant Growth During Forecast Period

Figure 6.           Anaphylaxis Treatment Market, by Geography (US$ Million)

Figure 7.           Global Anaphylaxis Treatment Market – Leading Country Markets (US$ Million)

Figure 8.           Global Anaphylaxis Treatment Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Global Anaphylaxis Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 15.        Global Anaphylaxis Treatment Market – By Geography Forecast and Analysis – 2020- 2028

Figure 16.        Market Positioning of Key Players in Global Anaphylaxis Treatment Market

Figure 17.        Anaphylaxis Treatment Market Revenue Share, by Medication Type (2020 and 2028)

Figure 18.        Epinephrine: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Antihistamines: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Steroids: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Beta-Agonist: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Anaphylaxis Treatment Market Revenue Share, Route of Administration (2020 and 2028)

Figure 24.        Oral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Parenteral: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Anaphylaxis Treatment Market Share, by Allergy Type, 2020 and 2028 (%)

Figure 28.        Food Allergy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Medications: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Insect Stings: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Others: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Anaphylaxis Treatment Market, by Distribution Channel, 2020 and 2028 (%)

Figure 33.        Retail Sales: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 34.        Hospital Pharmacies: Anaphylaxis Treatment Market - Revenue and Forecast to 2028 (US$ Mn)

Figure 35.        Others: Anaphylaxis Treatment Market, Revenue and Forecast to 2028 (US$ Mn)

Figure 36.        North America: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 37.        North America Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 38.        North America: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

Figure 39.        US: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Canada: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Mexico: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 42.        Europe: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 43.        Europe Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 44.        Europe: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

Figure 45.        Germany: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 46.        UK: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 47.        France: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 48.        Italy: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Spain: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        Rest of Europe: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Asia Pacific: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 52.        Asia Pacific: Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 53.        Asia Pacific: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

Figure 54.        Japan: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 55.        China: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 56.        India: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 57.        South Korea: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 58.        Australia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 59.        Rest of Asia Pacific: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 60.        Middle East & Africa: Anaphylaxis Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 61.        Middle East & Africa: Anaphylaxis Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 62.        Middle East and Africa: Anaphylaxis Treatment Market, by Country, 2020 & 2028 (%)

Figure 63.        Saudi Arabia: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 64.        UAE: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 65.        South Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 66.        Rest of Middle East and Africa: Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 67.        South and Central America: Anaphylaxis Treatment Market, By Key Country – Revenue (2020) (USD Million)

Figure 68.        South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)

Figure 69.        South and Central America: Anaphylaxis Treatment Market Share by Country – 2020 & 2028, (%)

Figure 70.        Brazil: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)

Figure 71.        Argentina: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028 (USD Million)

Figure 72.        Rest of South and Central America: Anaphylaxis Treatment Market- Revenue and Forecasts To 2028  (USD Million)

Figure 73.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 74.        Impact of COVID-19 Pandemic in European Country Markets

Figure 75.        Impact of COVID-19 Pandemic in Asia-Pacific Countries Markets

Figure 76.        Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 77.        Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 78.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Anaphylaxis Treatment Market

  1. Amneal Pharmaceuticals Inc.
  2. Bioprojet
  3. Mylan N.V.
  4. Adamis Pharmaceutical Corporation
  5. Abbott
  6. Pfizer Inc.
  7. Glaxosmithkline Plc.,
  8. Merck And Co., Inc.
  9. Teva Pharmaceutical Industries Ltd.           
  10. ALK-ABELLó
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the anaphylaxis treatment market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global anaphylaxis treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00022791
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response.

The growth of the anaphylaxis treatment market is attributed to the factors such as rising incidence of anaphylaxis, and recent approvals of epinephrine. Moreover, rise in cases of allergies post administration of covid-19 vaccines is also favoring the growth of the market

The anaphylaxis treatment market majorly consists of the players such as Amneal Pharmaceuticals Inc., Bioprojet, Mylan N.V., Adamis Pharmaceutical Corporation, Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck And Co. Inc., Teva Pharmaceutical Industries Ltd., ALK-ABELLó among others.

Pricing